Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anakinra in Refractory Idiopathic Inflammatory Myopathies
NCT01165008Phase 3Completed
- Sponsor
- Karolinska Institutet
- Start
- Sep 2003
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of anakinra in polymyositis (PM), dermatomyositis (DM) and inclusion body myositis (IBM), sponsored by Karolinska Institutet. Primary endpoints: International Myositis Assessment and Clinical Studies Group Score at 12 months and Functional Index of Myositis at 12 months. Started Sep 2003; status: completed.
02
Drugs
anakinra
03
Conditions
polymyositis (PM)dermatomyositis (DM)inclusion body myositis (IBM)
Beyond the preview
Go deeper on NCT01165008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01165008.